Ralph A. Tripp

Dr. Ralph A. Tripp is a Professor in the Department of Infectious Diseases at the University of Georgia's College of Veterinary Medicine and a Georgia Research Alliance Eminent Scholar in Vaccine and Therapeutics. His research focuses on respiratory virus immunology, antiviral development, and vaccine strategies targeting pathogens like influenza, RSV, and SARS-CoV-2. He leads a lab investigating virus-host interactions, immune responses, and diagnostic technologies such as surface-enhanced Raman spectroscopy (SERS) integrated with machine learning for rapid pathogen detection.

Dr. Tripp holds adjunct professorships at the University of Canberra (Australia), the University of Liverpool (UK), and Deakin University (Australia). His work emphasizes translational medicine, including probenecid's antiviral potential, nanoparticle vaccine design, and host-directed therapies to combat emerging respiratory viruses. Key achievements include developing diagnostic tools for SARS-CoV-2 variants and advancing RSV vaccine candidates with improved immunogenicity.

Scientific contributions span over 150 peer-reviewed articles, with a focus on viral pathogenesis, immune modulation, and innovative antiviral strategies. Awards include the GRA Eminent Scholar designation, recognizing his impactful research in vaccine science and therapeutics.